Elevated Anti-TPO with Normal TSH: What It Means and Is It Already Hashimoto’s?

Thyroid peroxidase (TPO) is an enzyme in thyroid cells that is essential for hormone synthesis. Anti-TPO antibodies arise when the immune system recognises it as “foreign” — they are one of the main markers of autoimmune thyroiditis, including Hashimoto’s disease. The antibody itself is not a disease, though: it is a trace of an autoimmune reaction that in some people leads to gradual destruction of the thyroid and in others has no consequences for a long time.

The most important conclusion from these data is reassuring: positive anti-TPO is a common result. If one in nine people without diagnosed thyroid disease has positive antibodies, not every such result can be treated like a diagnosis of disease. At the same time, the same material showed that anti-TPO are significantly associated with disturbances of thyroid function — so this is not a result without significance either.

In practice the diagnosis of Hashimoto’s disease rests on the whole picture: antibodies, hormone results (TSH, FT4), often the appearance of the thyroid on ultrasound (reduced echogenicity, heterogeneous structure) and symptoms. Positive anti-TPO with a normal TSH and FT4 and no ultrasound changes is, according to many doctors, “thyroid autoimmunity without hypothyroidism” — a state that may, but need not, progress to symptomatic disease. Some clinicians call it Hashimoto’s in the euthyroid phase, others reserve the name for people with an abnormal ultrasound or hormones. The difference is mostly terminological; the key is to understand what the result implies for treatment.

For treatment, little follows: with a normal TSH and FT4, levothyroxine is not indicated, because there is no hormone deficiency to make up. What changes is the frequency of monitoring. It is also worth knowing that the antibody titre (the number) is not a good measure of the severity of disease, and its fluctuations in successive tests rarely change management by themselves — decisions are made on the basis of TSH and FT4.

Remember too that reference ranges and methods of measuring anti-TPO differ between laboratories, so a result slightly above the threshold in one laboratory may be “normal” in another. When in doubt, for example with a borderline result and no symptoms, the doctor may order a repeat in the same laboratory. If you want to know how to distinguish symptoms of hypothyroidism from other causes of feeling unwell, see our article on hypothyroidism symptoms that are easy to confuse with other conditions and on the situation when TSH is normal but symptoms are present.

These data give a picture of risk, not of foregone conclusion: anti-TPO raise the chance of hypothyroidism many times over compared with people without antibodies, especially when TSH is already in the upper part of the range, but most people with positive antibodies do not develop hypothyroidism overnight. In other words: the higher the TSH at the time the antibodies are detected, the more closely one must watch. A TSH of about 2 mU/L or higher with positive anti-TPO is a good reason for regular checks.

Together these three sources form a consistent, if uncomfortable, story. First, anti-TPO are linked with a higher risk of miscarriage and preterm birth (observational data). Second, two large randomised trials — TABLET with 952 women and T4LIFE with 187 (stopped early because of slow recruitment) — did not show that levothyroxine in women with a normal TSH increased the live-birth rate. An association therefore does not have to mean that the antibodies themselves harm the pregnancy, or that supplementing the hormone will remove the risk; the antibodies may rather be a marker of something else (general autoimmunity, age, other factors). Third, observation of the women in TABLET showed that about 7% develop hypothyroidism, which justifies checking TSH before pregnancy and early in it — not routine preventive treatment.

The internet is full of advice to “lower the antibodies” with selenium or vitamin D when anti-TPO is positive. It is worth separating two questions: do the supplements lower the level of antibodies, and do they improve something we genuinely care about (symptoms, thyroid function, pregnancy outcomes)? To the first question the meta-analyses answer partly in the affirmative; to the second the answer is much less certain.

A cautious but honest conclusion: in diagnosed Hashimoto’s, selenium and vitamin D lower antibody titre in randomised trials, but lowering titre is not the same as improving health, and for people with isolated antibodies and a normal TSH there is no evidence of clinical benefit. In practice: checking the 25(OH)D level and correcting a deficiency makes sense for many reasons independent of the thyroid (we write about vitamin D3 in a separate entry), whereas taking selenium “just in case” without indication is not supported by evidence and carries the risk of excess if too high doses are taken for a long time.

Such a plan is clinical practice rather than a strict rule derived from randomised trials. The doctor chooses the frequency of checks according to age, TSH value, family history, other autoimmune diseases and plans for having children. If TSH rises on successive tests, what is more useful than re-measuring the antibodies is precisely what is described in our article on subclinical hypothyroidism.

Positive anti-TPO with a normal TSH is an example of a result that is significant but not urgent. It says something about the thyroid’s future, not about what has to be done today. Good practice is not to panic and not to look for a “drug for antibodies”, but to set a simple plan: TSH checks at set intervals, particular attention when planning a pregnancy, an ultrasound assessment, avoiding iodine and supplement overdosing, and a prompt reaction to new symptoms. In most cases that is enough, and the antibodies remain just a result in the file.